Publisher
Springer Science and Business Media LLC
Reference25 articles.
1. Rajkumar SV (2022) Multiple myeloma: 2022 update on diagnosis, risk stratification, and management. Am J Hematol 97(8):1086–1107. https://doi.org/10.1002/ajh.26590
2. Cowan AJ, Green DJ, Kwok M, Lee S, Coffey DG, Holmberg LA, Tuazon S, Gopal AK, Libby EN (2022) Diagnosis and management of multiple myeloma: a review. JAMA 327(5):464–477. https://doi.org/10.1001/jama.2022.0003
3. Zhou L, Yu Q, Wei G, Wang L, Huang Y, Hu K, Hu Y, Huang H (2021) Measuring the global, regional, and national burden of multiple myeloma from 1990 to 2019. BMC Cancer 21(1):606. https://doi.org/10.1186/s12885-021-08280-y
4. IHME (2015) Institute for Health Metrics and Evaluation (IHME). GBD Compare. Seattle, WA: IHME, University of Washington. https://www.healthdata.org/. Accessed November 2023
5. Brasil (2023) Ministério da Saúde. Diretrizes Diagnósticas e Terapêuticas do Mieloma Múltiplo. https://www.gov.br/conitec/pt-br/midias/consultas/relatorios/2022/20220526_ddt_mieloma_multiplo_cp.pdf. Accessed